Dosing of Intra-articular Triamcinolone Hexacetonide for Knee Synovitis in Chronic Polyarthritis
Status:
Unknown status
Trial end date:
2018-06-20
Target enrollment:
Participant gender:
Summary
This prospective randomised controlled single blind trial comparing the relapse rate in 6
months for 20 mg versus 40 mg intraarticular triamcinolone hexacetonide (Lederspan®) for knee
synovitis in patients with rheumatoid arthritis (RA) and psoriatic artritis (PsoA) is
performed to find the optimal dose to use.